These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3277024)

  • 1. Ciprofloxacin.
    Med Lett Drugs Ther; 1988 Jan; 30(758):11-3. PubMed ID: 3277024
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ciprofloxacin in the treatment of respiratory infections. Analysis of an Italian series].
    Maggiolo F; Bianchi W; Ohnmeiss H
    G Ital Chemioter; 1988; 35(1-3):39-44. PubMed ID: 3256511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of ciprofloxacin in bacterial infections of the respiratory and gastrointestinal tract].
    Sforza E; De Gennaro M; Ruggieri A; Ninno D; Pastore G
    Riv Eur Sci Med Farmacol; 1988 Dec; 10(6):533-7. PubMed ID: 3274737
    [No Abstract]   [Full Text] [Related]  

  • 4. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin in the treatment of infections at different sites.
    Peralta S; Accursio A; Filaci G; Vitale B; D'Aiello G; Scarsi C; Collura D; Rini GB
    J Chemother; 1989 Jul; 1(4 Suppl):674-5. PubMed ID: 16312587
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study].
    Sollich V; Klöditz E; Schuster R; Handrick W; Brömme S; Rumler W; Patsch R; Kharari H; Spencker FB
    Kinderarztl Prax; 1993 Aug; 61(6):211-4. PubMed ID: 8411847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ
    Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous ciprofloxacin.
    Med Lett Drugs Ther; 1991 Aug; 33(850):75-6. PubMed ID: 2072876
    [No Abstract]   [Full Text] [Related]  

  • 13. Ciprofloxacin.
    Kulshrestha SP; Barar FS; Miglani N
    Indian Pediatr; 1990 Aug; 27(8):849-53. PubMed ID: 2152246
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciprofloxacin: an overview and prospective appraisal.
    Neu HC
    Am J Med; 1987 Apr; 82(4A):395-404. PubMed ID: 3578329
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ciprofloxacin, the most efficacious quinolone in the therapy of infectious respiratory lesions].
    Mihălţan F; Popescu O
    Pneumoftiziologia; 1992; 41(1):63-7. PubMed ID: 1299405
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
    Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of infection in respiratory tract diseases].
    Internist (Berl); 1995 Sep; 36(9 Suppl Infektions):1-4. PubMed ID: 9131079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and pharmacokinetic study of ciprofloxacin at the level of the respiratory system].
    De Rose V; Mangiarotti P; Ferrara AM; Bertoletti R; Grassi G; Manara G; Grassi C
    G Ital Chemioter; 1987; 34(1-3):57-61. PubMed ID: 3504415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.